India, Oct. 2 -- Global pop star Alex Warren has announced that he will perform a batch of concerts across the U.K. and Europe in the summer of 2027. The nine-date run, named "Finding (More) Family O... Read More
India, Oct. 1 -- Cullinan Therapeutics (CGEM) announced that it has initiated submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration for zipalertinib in combination with p... Read More
India, Oct. 1 -- On Thursday, Light Science Technologies Holdings Plc (LST.L), a business solutions provider, published a trading update for the year of 2026. The Company now expects 2026 revenue of ... Read More
India, Oct. 1 -- Thursday, Sun Pharmaceutical Industries Limited (SUNPHARMA) reported two-year safety and efficacy data for LEQSELVI (deuruxolitinib) in adults with severe alopecia areata at the 2026 ... Read More
India, Oct. 1 -- Thursday, Hyundai Motor Company (005380.KS) announced a record September total sales of 77,439 units in America, an increase of 9 percent from last year. The September sales were led... Read More
India, Oct. 1 -- After failing to sustain an initial move to the upside, stocks have moved mostly lower over the course of the trading session on Thursday. The major averages have all moved to the dow... Read More
India, Oct. 1 -- On Thursday, Akari Therapeutics (AKTX) said it filed a new PCT application covering its PH1 payload and its ability to disrupt multiple cancer-driving pathways through RNA splicing mo... Read More
India, Oct. 1 -- International Business Machines Corp. (IBM) is up 4.22 percent, gaining $9.29 to $229.22 on Thursday. The move comes after IBM announced a self-hosted deployment option for IBM Bob, i... Read More
India, Oct. 1 -- Thursday, Candel Therapeutics (CADL) reported final Phase 2a data for aglatimagene besadenovec plus valacyclovir in patients with unresectable Stage III/IV non-small cell lung cancer ... Read More
India, Oct. 1 -- Candel Therapeutics (CADL) reported final Phase 2a results showing a median overall survival of 24.5 months with aglatimagene besadenovec plus valacyclovir in patients with advanced N... Read More